BR112023015769A2 - Vetor de vírus adenoassociado de rna (raav) e usos do mesmo - Google Patents

Vetor de vírus adenoassociado de rna (raav) e usos do mesmo

Info

Publication number
BR112023015769A2
BR112023015769A2 BR112023015769A BR112023015769A BR112023015769A2 BR 112023015769 A2 BR112023015769 A2 BR 112023015769A2 BR 112023015769 A BR112023015769 A BR 112023015769A BR 112023015769 A BR112023015769 A BR 112023015769A BR 112023015769 A2 BR112023015769 A2 BR 112023015769A2
Authority
BR
Brazil
Prior art keywords
raav
adeno
vector
rna
rna virus
Prior art date
Application number
BR112023015769A
Other languages
English (en)
Inventor
Linyu Shi
Weiya Bai
Original Assignee
Huidagene Therapeutics Singapore Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huidagene Therapeutics Singapore Pte Ltd filed Critical Huidagene Therapeutics Singapore Pte Ltd
Publication of BR112023015769A2 publication Critical patent/BR112023015769A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14123—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/48—Vector systems having a special element relevant for transcription regulating transport or export of RNA, e.g. RRE, PRE, WPRE, CTE
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

vetor de vírus adenoassociado de rna (raav) e usos do mesmo. é fornecida uma sequência de rna compreendendo uma sequência de rna de interesse e um sinal de empacotamento de rna. também é fornecida uma partícula viral de vírus de dna recombinante compreendendo a sequência de rna compreendendo uma sequência de rna de interesse e um sinal de empacotamento de rna empacotada dentro da cápsula proteica de um vírus de dna.
BR112023015769A 2021-02-07 2022-02-07 Vetor de vírus adenoassociado de rna (raav) e usos do mesmo BR112023015769A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2021075874 2021-02-07
PCT/CN2022/075366 WO2022166954A1 (en) 2021-02-07 2022-02-07 Rna adeno-associated virus (raav) vector and uses thereof

Publications (1)

Publication Number Publication Date
BR112023015769A2 true BR112023015769A2 (pt) 2023-12-12

Family

ID=74946911

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023015769A BR112023015769A2 (pt) 2021-02-07 2022-02-07 Vetor de vírus adenoassociado de rna (raav) e usos do mesmo

Country Status (10)

Country Link
US (1) US20230062529A1 (pt)
EP (1) EP4288112A1 (pt)
JP (1) JP2024508696A (pt)
KR (1) KR20230142776A (pt)
CN (1) CN115209924A (pt)
AU (1) AU2022217349A1 (pt)
BR (1) BR112023015769A2 (pt)
CA (1) CA3207601A1 (pt)
IL (1) IL305002A (pt)
WO (1) WO2022166954A1 (pt)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9790490B2 (en) * 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
CN110312799A (zh) * 2016-08-17 2019-10-08 博德研究所 新型crispr酶和系统
US11352647B2 (en) * 2016-08-17 2022-06-07 The Broad Institute, Inc. Crispr enzymes and systems
US20230190958A1 (en) * 2017-01-13 2023-06-22 Jichi Medical University AAV Vector for Disrupting Coagulation Factor-Related Gene on Liver Genome
CN109055375B (zh) * 2018-07-26 2021-11-12 东南大学 一种crispr辅助反式增强子激活基因表达的方法及其应用
CN111349148A (zh) * 2020-03-13 2020-06-30 辉大(上海)生物科技有限公司 一种腺相关病毒载体及其用途

Also Published As

Publication number Publication date
CN115209924A (zh) 2022-10-18
CA3207601A1 (en) 2022-08-11
JP2024508696A (ja) 2024-02-28
US20230062529A1 (en) 2023-03-02
IL305002A (en) 2023-10-01
WO2022166954A1 (en) 2022-08-11
AU2022217349A1 (en) 2023-08-31
EP4288112A1 (en) 2023-12-13
KR20230142776A (ko) 2023-10-11

Similar Documents

Publication Publication Date Title
BR112021020054A2 (pt) Capsídeos de vírus adeno-associado (aav) e composições contendo os mesmos
CL2020000728A1 (es) Variantes de cápsides de virus adenoasociados y métodos de uso de estas.
MX2022014256A (es) Redirección del tropismo de las cápsides de aav.
MX2017012097A (es) Variantes de virus adenoasociado y métodos de uso de estas.
PH12018500594A1 (en) Adeno-associated virus factor viii vectors, associated viral particles and therapeutic formulations comprising the same
PH12020551938A1 (en) Liver targeting adeno-associated viral vectors
BR112021018776A2 (pt) Vetores de vírus adenoassociado recombinante
PH12020550706A1 (en) Adeno-associated virus variant capsids and use for inhibiting angiogenesis
DE602005026269D1 (de) Sequenzielle freisetzung immunogener moleküle über adenoviren und adeno-assoziierte viren vermittelte abgaben
WO2018160573A8 (en) Influenza vaccines based on aav vectors
EA202091352A1 (ru) Генотерапия мукополисахаридоза iiib
CO2021016198A2 (es) Composiciones útiles para el tratamiento de la enfermedad de pompe
BRPI0407840A (pt) polipeptìdeo purificado, anticorpo policlonal ou monoclonal purificado, vetor de expressão, seqüência de polinucleotìdeo purificada, uso de uma seqüência de polinucleotìdeo, vetor viral recombinante, vìrus do sarampo recombinante, composição farmacêutica, uso da mesma, célula hospedeira, método para produzir um vìrus recombinante para a produção de um vìrus recombinante, linhagem de células, ensaio de neutralização de vìrus do nilo ocidental, e, método para tratar e/ou prevenir uma infecção ou doença associada com wnv ou vìrus do dengue em um animal
BR112023024375A2 (pt) Vírus adeno-associado recombinante tendo capsídeo variante e sua aplicação
AR108014A1 (es) Vacuna universal para enfermedades virales y método de vacunación
MX2022013819A (es) Capsides de virus adeno-asociado 5 modificado y usos del mismo.
BR112023015769A2 (pt) Vetor de vírus adenoassociado de rna (raav) e usos do mesmo
MX2021012489A (es) Lineas celulares productoras dise?adas geneticamente y metodos de elaboracion y uso de las mismas.
Hegde et al. Human cytomegalovirus US2 causes similar effects on both major histocompatibility complex class I and II proteins in epithelial and glial cells
EP3922724A4 (en) RECOMBINANT VECTOR WITH IMMUNOGENIC PROTEIN OF SWINE AFRICAN FEVER VIRUS, RECOMBINANT BACTERIA AND THEIR USES
AR119869A1 (es) Proteína vp1 modificada aislada de la cápside del virus adeno-asociado de serotipo 5 (aav5), cápside y vector basado en la misma
MX2022000551A (es) Proteínas de la cápside de aav modificadas para el tratamiento de una enfermedad artrítica.
Kuzmenko et al. Intracellular degradation and localization of NS1 of tick-borne encephalitis virus affect its protective properties
Hetrick et al. Development of a novel hybrid alphavirus-SARS-CoV-2 particle for rapid in vitro screening and quantification of neutralization antibodies, viral variants, and antiviral drugs
WO2007144886A3 (en) Virus-like particles for treatment of viral infections